Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Non Operating Income (2023 - 2024)

Historic Non Operating Income for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to $2.5 million.

  • Contineum Therapeutics' Non Operating Income rose 4215.35% to $2.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.6 million, marking a year-over-year increase of 2176.79%. This contributed to the annual value of $8.6 million for FY2024, which is 2175.38% up from last year.
  • As of Q4 2024, Contineum Therapeutics' Non Operating Income stood at $2.5 million, which was up 4215.35% from $2.7 million recorded in Q3 2024.
  • Contineum Therapeutics' 5-year Non Operating Income high stood at $3.4 million for Q2 2023, and its period low was $291000.0 during Q1 2023.